Expanded Approvals for Durvalumab, Lu 177 vt; Portland Preview Podcast Por  arte de portada

Expanded Approvals for Durvalumab, Lu 177 vt; Portland Preview

Expanded Approvals for Durvalumab, Lu 177 vt; Portland Preview

Escúchala gratis

Ver detalles del espectáculo

Acerca de esta escucha

FDA expands approvals for durvalumab (bladder cancer) and Lutetium-177 vipivotide tetraxetan (pre-taxane in metastatic prostate cancer). Portland has places.
adbl_web_global_use_to_activate_T1_webcro805_stickypopup
Todavía no hay opiniones